Our laboratory demonstrated previously that an upregulation of NOS II through NF-κB activation at RVLM [20] plays a pivotal role in eliciting defunct brain stem cardiovascular regulation during experimental endotoxemia. Here, NFKB1 is linked to serum lipopolysaccharide activity.